Catecholamine Research

1. Front Matter

   Pages i-xxiv

   PDF

2. In Memorium

   1. In Memory of Dr. Sidney Udenfriend

      • Toshiharu Nagatsu

      Pages 1-4

3. Dr. Sidney Udenfriend Memorial Lecture

   1. Molecular Genetics of Catecholamines: Key Molecules Bridging Basic Science with Clinical Science

      • Toshiharu Nagatsu

      Pages 5-17

4. Catecholamine Uptake, Storage, and Release

   1. Chromogranins / Current Concept

      • Dominique Aunis, Marie-Hélène Metz-Boutigue

      Pages 19-22

   2. The Vesicular Monoamine Transporters (VMATs): Role in the Chemical Coding of Neuronal Transmission and Monoamine Storage in Amine-Handling Immune and Inflammatory Cells

      • L. E. Eiden, B. Schütz, M. Anlauf, C. Depboylu, M. K.-H. Schäfer, E. Weihe

      Pages 23-33

   3. Mutants and Variants of the Human Antidepressant-Sensitive Norepinephrine Transporter

      • Heinz Bönisch, Philipp Wiedemann, Fabian Runkel, Bruno Giros, Christine Roubert, Michael Brüss

      Pages 35-38

   4. D2 Receptor-Mediated Regulation of Vesicular Dopamine Uptake

      • Annette E. Fleckenstein, Jeffrey M. Brown, Verónica Sandoval, Evan L. Riddle, J. Paul Hansen, Yvette V. Ugarte et al.

      Pages 39-42

   5. A Varicosity Ensemble Model of Sympathetic Neuromuscular Transmission

      • Lennart Stjärne

      Pages 43-46

   6. Single Sympathetic Varicosities and Their Receptor Clusters

      • Max R. Bennett

      Pages 47-51

   7. Enhancement of Noradrenergic Phenotype Expression in Transgenic Mice Overexpressing V-1, A Cytoplasmic Ankyrin Repeat Protein

      • Tohru Yamakuni, Toshifumi Yamamoto, Hideko Yamamoto, Si-Young Song, Toshiharu Nagatsu, Kazuto Kobayashi et al.

      Pages 53-56

   8. Multiple Roles of Actin Cytoskeleton in Catecholamine Release from Chromaffin Cell

      • Konosuke Kumakura, Mica Ohara-Imaizumi, Fiorenzo Battaini, Nobuyuki Sasakawa, Shingo Ohkubo

      Pages 57-60

   9. Interaction of Tyrosine Hydroxylase and 14–3–3 Proteins in PC12 Cells

      • Tohru Ichimura, Chiharu Itagaki, Akiko Wakamiya, Toshiaki Isobe

      Pages 61-64

   10. Acetylcholinesterase Inhibitor Elicits Muscarinic Receptor-Mediated Cholinergic Transmission in the Rat Adrenal Medulla

       • Tsuyoshi Akiyama, Toji Yamazaki, Hidezo Mori

       Pages 65-68

   11. Leptin Stimulates Catecholamine Synthesis via Tyrosine Hydroxylase Phosphorylation-Dependent and -Independent Pathways in Cultured Bovine Adrenal Medullary Cells

       • Nobuyuki Yanagihara, Kensuke Utsunomiya, Yumiko Toyohira, Susumu Ueno, Masato Tsutsui, Tat Beng Cheah et al.

       Pages 69-72

   12. Sympathetic Potentiation of Cyclic ADP-Ribose Formation in Rat Cardiac Myocytes

       • Haruhiro Higashida, Jia-Sheng Zhang, Shigeru Yokoyama, Mami Noda, Zhen-Guo Zhong, Sumiko Mochida et al.

       Pages 73-76

   13. Rab3A Small G Protein and Its Regulators in Neurotransmitter Release and Synaptic Plasticity

       • Hiroyuki Nakanishi, Takuya Sasaki, Jun Miyoshi, Yoshimi Takai

       Pages 77-80

   14. Assessing Sympathetic Function from Dynamics of Norepinephrine Metabolism and False Transmitters

       • Irwin J. Kopin

       Pages 81-86

   15. Adenylyl Cyclase: A Molecule of Diversity

       • Yoshihiro Ishikawa

       Pages 87-90

   16. L-Dopa Uptake and Decarboxylation in the Brain

       • Kunio Kitahama, Ryohachi Arai, Michel Geffard, Nobuyuki Karasawa, Ikuko Nagatsu

       Pages 91-94

   17. Dopamine Synthesis from L-Tyrosine by Non-Dopaminergic Neurons in Co-Operation

       • Michael V. Ugrumov, Petr V. Ershov, Irina S. Balan

       Pages 95-98

This book is based on invited presentations at the Ninth International Catecholamine Symposiwn. Over several decades, each International Catecholamine Symposiwn (ICS) has provided a uniquely important forwn for updating basic as well as clinical research on the catecholamines, dopamine, norepinephrine, and epinephrine. The first ICS took nd n1 place in Bethesda, Maryland, in the USA in 1958; the 2 in Milan, Italy in 1965; the 3 th in Strasbourg, France in 1973; the 4th in Asilomar, California, USA in 1978; the 5 in th th Goteborg, Sweden in 1983; the 6 in Jerusalem, Israel,in 1987; the 7 in Amsterdam, th Netherlands in 1992; and the 8 in Asilomar, California, USA in 1996. th The 9 International Catecholamine Symposiwn (9ICS) was held in Kyoto, Japan, th March 31-April 5, 2001. This ICS was held concurrently with the 5 International th Conference on Progress in Alzheimer's and Parkinson's Disease (5 ADPD). These international meetings were coordinated to be a joint international congress. Catecholamines and related neurotransmitters and neuromediators play important roles in the pathogenesis of symptoms and neurodegenerative processes of Alzheimer's disease and Parkinson's disease. Therefore, the Joint Congress provided an opportunity for investigators and clinicians working in these fields to exchange their· most recent investigational results and clinical experiences. This Joint International Congress turned out to be an enormous success, attended by 1258 participants from 38 countries, in an enthusiastic and pleasant atmosphere.

• cardiovascular
• cardiovascular function
• catecholamines
• neurobiology
• psychiatric disorder

• Fujita Health University, Toyoake, Aichi, Japan

  Toshiharu Nagatsu

• Nagoya University, Nagoya, Japan

  Toshitaka Nabeshima

• Vanderbilt University, Nashville, USA

  Richard McCarty

• National Institute of Neurological Disorders and Stroke, Bethesda, USA

  David S. Goldstein

Policies and ethics